Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
出版年份 2020 全文链接
标题
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the
Cardio‐Oncology Study Group
of the
Heart Failure Association
and the
Cardio‐Oncology Council of the European Society of Cardiology
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HEART FAILURE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-10-02
DOI
10.1002/ejhf.2017
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy
- (2020) Faizi A. Jamal et al. Current Hematologic Malignancy Reports
- Diagnostic Accuracy of a High-Sensitivity Cardiac Troponin Assay with a Single Serum Test in the Emergency Department
- (2019) Richard Body et al. CLINICAL CHEMISTRY
- High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction
- (2019) Jasper Boeddinghaus et al. CLINICAL CHEMISTRY
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
- (2019) Christian Mueller et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer
- (2019) Katelyn M. Atkins et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Use of a New High-Sensitivity Cardiac Troponin I Assay in Patients with Suspected Myocardial Infarction
- (2019) Jasper Boeddinghaus et al. CLINICAL CHEMISTRY
- Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
- (2019) Robert F. Cornell et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic Evaluation of a High-Sensitivity Troponin I Point-of-Care Assay
- (2019) Nils A. Sörensen et al. CLINICAL CHEMISTRY
- Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta‐analysis
- (2019) Lars Michel et al. EUROPEAN JOURNAL OF HEART FAILURE
- Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart
- (2019) Sarju Ganatra et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
- (2019) Raza M. Alvi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Failing Heart Stimulates Tumor Growth by Circulating Factors
- (2018) Wouter C. Meijers et al. CIRCULATION
- Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin
- (2018) Patrick Badertscher et al. CLINICAL CHEMISTRY
- Novel heart failure biomarkers: why do we fail to exploit their potential?
- (2018) Arnold Piek et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- The Role of Cardiac Biomarkers in Cardio-Oncology
- (2018) Elizabeth Riddell et al. CURRENT PROBLEMS IN CANCER
- Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial
- (2018) Ann Banke et al. EUROPEAN JOURNAL OF HEART FAILURE
- Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
- (2018) Kaviyarasi Renu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy
- (2018) Wilson Nadruz et al. HEART
- Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
- (2018) Mônica Samuel Avila et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department
- (2018) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
- (2018) Gilda Varricchi et al. Frontiers in Physiology
- Immune Checkpoint Inhibitor–Associated Myositis
- (2018) Céline Anquetil et al. CIRCULATION
- Fourth universal definition of myocardial infarction (2018)
- (2018) Kristian Thygesen et al. EUROPEAN HEART JOURNAL
- Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience
- (2018) Nilesh Pareek et al. EUROPEAN JOURNAL OF HEART FAILURE
- Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review
- (2018) Jan M Leerink et al. HEART
- Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease
- (2018) Philip D. Adamson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
- (2018) Weijie Du et al. Theranostics
- The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer
- (2018) Imène Mansouri et al. EUROPEAN JOURNAL OF HEART FAILURE
- Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma
- (2018) Biniyam G. Demissei et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease
- (2017) Alida L.P. Caforio et al. EUROPEAN HEART JOURNAL
- Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience
- (2017) Alessandra Fornaro et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome
- (2017) Andrew R. Chapman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy
- (2017) Dimitrios Zardavas et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction
- (2017) Raphael Twerenbold et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer
- (2017) Brian S. Finkelman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High-sensitivity assays for troponin in patients with cardiac disease
- (2017) Dirk Westermann et al. Nature Reviews Cardiology
- High-sensitive troponin T assay can predict anthracycline- and trastuzumab-induced cardiotoxicity in breast cancer patients
- (2017) Hiromitsu Kitayama et al. Breast Cancer
- Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
- (2017) Geeta Gulati et al. Journal of the American Heart Association
- Cardiovascular Toxicities Associated with Cancer Immunotherapies
- (2017) Daniel Y. Wang et al. Current Cardiology Reports
- High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury
- (2017) Melissa Jones et al. ANNALS OF CLINICAL BIOCHEMISTRY
- 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction
- (2017) Raphael Twerenbold et al. CIRCULATION
- ErbB2 signaling at the crossing between heart failure and cancer
- (2016) Zarha Vermeulen et al. BASIC RESEARCH IN CARDIOLOGY
- Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac DysfunctionNovelty and Significance
- (2016) Lynn A. Beer et al. CIRCULATION RESEARCH
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
- (2016) Anthony F. Yu et al. ONCOLOGIST
- Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients
- (2016) Vagner Oliveira-Carvalho Rigaud et al. Oncotarget
- Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis
- (2015) Amara S. Hussain et al. AMERICAN JOURNAL OF HEMATOLOGY
- Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
- (2015) M. Putt et al. CLINICAL CHEMISTRY
- Cardiac endothelium–myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction
- (2015) Shir Lynn Lim et al. EUROPEAN HEART JOURNAL
- Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy
- (2015) Evandro de Azambuja et al. EUROPEAN JOURNAL OF CANCER
- State of the Art: Newer biomarkers in heart failure
- (2015) Rudolf A. de Boer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
- (2015) Noemi Pavo et al. HEART
- Patterns of Cardiac Toxicity Associated With Irreversible Proteasome Inhibition in the Treatment of Multiple Myeloma
- (2015) E. Wilson Grandin et al. JOURNAL OF CARDIAC FAILURE
- Genetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload
- (2015) Mark J. Ranek et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study
- (2015) Anoop S V Shah et al. LANCET
- Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
- (2015) Saro H Armenian et al. LANCET ONCOLOGY
- ACE inhibition attenuates radiation-induced cardiopulmonary damage
- (2015) Sonja J. van der Veen et al. RADIOTHERAPY AND ONCOLOGY
- Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients
- (2015) Francesca De Iuliis et al. TUMOR BIOLOGY
- Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib
- (2015) S Atrash et al. Blood Cancer Journal
- High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
- (2015) Anoop S V Shah et al. BMJ-British Medical Journal
- High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
- (2015) Anoop S V Shah et al. BMJ-British Medical Journal
- High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis
- (2014) C. W. L. Chin et al. EUROPEAN HEART JOURNAL
- BNP Predicts Chemotherapy-Related Cardiotoxicity and Death: Comparison with Gated Equilibrium Radionuclide Ventriculography
- (2014) Dorthe Skovgaard et al. PLoS One
- Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure
- (2013) Mark Ledwidge et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)
- (2013) Martin Huelsmann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
- (2013) Bonnie Ky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma Patients
- (2013) Philip S. Hall et al. JACC-Heart Failure
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
- (2012) Heloisa Sawaya et al. Circulation-Cardiovascular Imaging
- Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section
- (2012) James L. Januzzi et al. EUROPEAN HEART JOURNAL
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
- (2011) Heloisa Sawaya et al. AMERICAN JOURNAL OF CARDIOLOGY
- Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib
- (2011) P. G. Morris et al. CLINICAL CANCER RESEARCH
- Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
- (2011) F. S. Apple et al. CLINICAL CHEMISTRY
- Biomonitoring and Biomarker-Guided Therapy
- (2011) Alan Maisel JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NT-proBNP: A cardiac biomarker to assess prognosis in non-Hodgkin lymphoma
- (2011) Eva Gimeno et al. LEUKEMIA RESEARCH
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- In the End What Matters Most? A Review of Clinical Endpoints in Advanced Breast Cancer
- (2011) S. Verma et al. ONCOLOGIST
- Frequency and management of troponin I elevation in patients treated with molecular targeted therapies in phase I trials
- (2010) Stephane Ederhy et al. INVESTIGATIONAL NEW DRUGS
- Troponin I Provides Insight Into Cardiotoxicity and the Anthracycline-Trastuzumab Interaction
- (2010) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- (2010) Daniela Cardinale et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
- (2010) Michael S. Ewer et al. Nature Reviews Cardiology
- Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide
- (2009) Mauro Feola et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays
- (2009) Tobias Reichlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines
- (2009) Annelies M.C. Mavinkurve-Groothuis et al. PEDIATRIC BLOOD & CANCER
- Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity
- (2008) J. M. Horacek et al. ANNALS OF ONCOLOGY
- State of the art: Using natriuretic peptide levels in clinical practice
- (2008) Alan Maisel et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started